-
1دورية أكاديمية
المؤلفون: Sun, Hongxia, Kang, Eun Young, Chen, Hui, Sweeney, Keith J., Suchko, Michael, Wu, Yun, Wen, Jianguo, Krishnamurthy, Savitri, Albarracin, Constance T., Ding, Qing-Qing, Foo, Wai Chin, Sahin, Aysegul A.Aff1, IDs10549024072563_cor12
المصدر: Breast Cancer Research and Treatment. 205(2):403-411
-
2دورية أكاديمية
المؤلفون: Ko HC, Seager RJ, Pabla S, Senosain MF, Van Roey E, Gao S, Strickland KC, Previs RA, Green MF, Cooper M, Nesline MK, Hastings SB, Amoah KA, Zhang S, Conroy JM, Jensen TJ, Eisenberg M, Caveney B, Severson EA, Ramkissoon S, Gandhi S
المصدر: Breast Cancer: Targets and Therapy, Vol Volume 16, Pp 483-495 (2024)
مصطلحات موضوعية: her2-low breast cancer, estrogen receptor, tumor immune microenvironment, immune checkpoint biomarkers, gene expression profiling, immune profiling, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Li, Chengxin, Yuan, Qianqian, Deng, Tong, Xu, Gaoran, Hou, Jinxuan, Zheng, Lewei, Wu, GaosongAff1, IDs1228202301487w_cor7
المصدر: Breast Cancer. 30(6):965-975
-
4
المؤلفون: Altena, Renske, af Buren, Siri, Blomgren, August, Karlsson, Emelie, Tzortzakakis, Antonios, Brun, Nikolai, Moein, Mohammad M., Jussing, Emma, Frejd, Fredrik, Bergh, Jonas, Tran, Thuy A., Hartman, Johan, Axelsson, Rimma
المصدر: Journal of Nuclear Medicine. 65(5):700-707
مصطلحات موضوعية: HER2 PET, HER2-low breast cancer, [ 68 Ga]Ga-ABY-025
وصف الملف: print
-
5دورية أكاديمية
المصدر: Cancers, Vol 16, Iss 10, p 1801 (2024)
مصطلحات موضوعية: antibody–drug conjugates, ADCs, hormone receptor-positive breast cancer, HER2-low breast cancer, HER2-negative breast cancer, endocrine resistance, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
6دورية أكاديمية
المؤلفون: Juan Jin, Bin Li, Jianing Cao, Ting Li, Jian Zhang, Jun Cao, Mingchuan Zhao, Leiping Wang, Biyun Wang, Zhonghua Tao, Xichun Hu
المصدر: Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-16 (2023)
مصطلحات موضوعية: HER2-low breast cancer, Antibody–drug conjugates, HER2 expression, HER2 dynamics, Metastatic breast cancer, Heterogeneity, Medicine
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1479-5876
-
7دورية أكاديمية
المصدر: Breast Cancer: Targets and Therapy, Vol Volume 15, Pp 281-294 (2023)
مصطلحات موضوعية: her2-low breast cancer, monoclonal antibodies, antibody–drug conjugates, trastuzumab deruxtecan, immunotherapy, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://www.dovepress.com/can-patients-with-her2-low-breast-cancer-benefit-from-anti-her2-therap-peer-reviewed-fulltext-article-BCTT; https://doaj.org/toc/1179-1314
-
8دورية أكاديمية
المؤلفون: Shuling Zhou, Ting Liu, Xiaying Kuang, Tiantian Zhen, Huijuan Shi, Ying Lin, Nan Shao
المصدر: Breast, Vol 67, Iss , Pp 1-7 (2023)
مصطلحات موضوعية: HER2-low breast cancer, Neoadjuvant chemotherapy, Pathological complete response, Survival, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
9دورية أكاديمية
المؤلفون: Yingying Zhao, Xinru Chen, Yaohui Wang, Xueqing Zhang, Jingsong Lu, Wenjin Yin
المصدر: Journal of Clinical Medicine, Vol 13, Iss 7, p 1850 (2024)
مصطلحات موضوعية: HER2-low breast cancer, prognosis, Neo-Bioscore, HER2-zero, HER2-positive, Medicine
وصف الملف: electronic resource
-
10دورية أكاديمية
المصدر: Breast Cancer: Targets and Therapy, Vol Volume 14, Pp 453-463 (2022)
مصطلحات موضوعية: cost-effectiveness, her2-low breast cancer, trastuzumab deruxtecan, partitioned survival approach, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource